Financials

News Ideas Technicals

IXC fundamentals

Overview Statements Statistics Dividends Earnings Revenue

An in-depth look to INVEX THERAPEUTICS LTD operating, investing, and financing activities

IXC free cash flow for H1 24 is -2.32 M AUD. For 2023, IXC free cash flow was -6.87 M AUD and operating cash flow was -6.87 M AUD.

‪0.00‬

Cash from operating activities

Cash from investing activities

Cash from financing activities

Income statement Balance sheet Cash flow

Currency: AUD

TTM

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—